000 | 01453 a2200397 4500 | ||
---|---|---|---|
005 | 20250517032616.0 | ||
264 | 0 | _c20160310 | |
008 | 201603s 0 0 eng d | ||
022 | _a1532-2513 | ||
024 | 7 |
_a10.3109/08923973.2015.1035392 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSon, Young Jun | |
245 | 0 | 0 |
_aImproved efficacy of soluble human receptor activator of nuclear factor kappa B (RANK) fusion protein by site-directed mutagenesis. _h[electronic resource] |
260 |
_bImmunopharmacology and immunotoxicology _cJun 2015 |
||
300 |
_a221-7 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAmino Acid Substitution |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aCHO Cells |
650 | 0 | 4 | _aCricetinae |
650 | 0 | 4 | _aCricetulus |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunoglobulins _xbiosynthesis |
650 | 0 | 4 | _aMutagenesis, Site-Directed |
650 | 0 | 4 | _aMutation, Missense |
650 | 0 | 4 | _aProtein Structure, Secondary |
650 | 0 | 4 |
_aReceptor Activator of Nuclear Factor-kappa B _xbiosynthesis |
650 | 0 | 4 |
_aRecombinant Fusion Proteins _xbiosynthesis |
650 | 0 | 4 | _aSolubility |
700 | 1 | _aHan, Jihye | |
700 | 1 | _aLee, Jae Yeon | |
700 | 1 | _aKim, HaHyung | |
700 | 1 | _aChun, Taehoon | |
773 | 0 |
_tImmunopharmacology and immunotoxicology _gvol. 37 _gno. 3 _gp. 221-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3109/08923973.2015.1035392 _zAvailable from publisher's website |
999 |
_c24900813 _d24900813 |